Skip to main content

Table 1 Association between clinical factors and HLA class I expression in 212 breast cancer patients

From: Clinical implication of HLA class I expression in breast cancer

  Positive (n = 69) Negative (n = 143) p value
Age (years)    
< 50 23 (11%) 59 (28%) 0.2669
51 < 46 (22%) 84 (40%)  
Tumor size    
T1 35 (17%) 51 (24%) 0.0641
T2 31 (15%) 72 (34%)  
T3 1 12 (57%)  
T4 2 8 (4%)  
Nodal invasion    
Negative 49 (23%) 79 (37%) 0.0278
Positive 20 (9%) 64 (30%)  
Estrogen receptor    
Negative 18 (8%) 53 (25%) 0.1126
Positive 51 (24%) 90 (42%)  
Progesterone receptor    
Negative 25 (12%) 64 (30%) 0.2387
Positive 44 (21%) 79 (37%)  
Lymphatic invasion    
Negative 46 (22%) 67 (32%) 0.0067
Positive 23 (11%) 76 (36%)  
Venous invation    
Negative 66 (31%) 122 (58%) 0.0260
Positive 3 (1%) 21 (10%)  
TNM    
I 31 (15%) 39 (18%) 0.0110
II 31 (15%) 70 (33%)  
III 7 (3%) 34 (16%)  
Histology    
IDC 67 (32%) 142 (67%) 0.2040
ILC 2 1  
HER2 receptor    
Negative 63 (30%) 123 (58%) 0.4539
Positive 6 (3%) 17 (8%)